Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges

被引：8
作者：
Ceresoli, Giovanni Luca [1 ]
Bonomi, Maria [1 ]
Sauta, Maria Grazia [1 ]
机构：
[1] Clin Humanitas Gavazzeni, Thorac & GU Oncol Unit, Dept Med Oncol, I-24125 Bergamo, Italy
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2016年 / 16卷 / 07期
关键词：
Malignant pleural mesothelioma; immunotherapy; immune-checkpoint inhibitors; SINGLE-ARM; OPEN-LABEL; TREMELIMUMAB; CISPLATIN; BLOCKADE; PHASE-2; CANCER; SAFETY;
D O I：
10.1080/14737140.2016.1191951
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：673 / 675
页数：3
相关论文
共 50 条
[41]   The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review [J].
Desage, Anne-Laure ;
Karpathiou, Georgia ;
Peoc'h, Michel ;
Froudarakis, Marios E. .
CANCERS, 2021, 13 (13)
[42]   The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma [J].
Perera, Nirosha D. ;
Mansfield, Aaron S. .
CURRENT ONCOLOGY REPORTS, 2022, 24 (11) :1413-1423
[43]   Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma [J].
Vita, Emanuele ;
Stefani, Alessio ;
Di Salvatore, Mariantonietta ;
Chiappetta, Marco ;
Lococo, Filippo ;
Margaritora, Stefano ;
Tortora, Giampaolo ;
Bria, Emilio .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
[44]   Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time [J].
Pasello, G. ;
Zago, G. ;
Lunardi, F. ;
Urso, L. ;
Kern, I ;
Vlacic, G. ;
Grosso, F. ;
Mencoboni, M. ;
Ceresoli, G. L. ;
Schiavon, M. ;
Pezzuto, F. ;
Pavan, A. ;
Vuljan, S. E. ;
Del Bianco, P. ;
Conte, P. ;
Rea, F. ;
Calabrese, F. .
ANNALS OF ONCOLOGY, 2018, 29 (05) :1258-1265
[45]   Use of Immune Checkpoint Inhibitors in Mesothelioma [J].
Patrick M. Forde ;
Arnaud Scherpereel ;
Anne S. Tsao .
Current Treatment Options in Oncology, 2019, 20
[46]   Immune checkpoint inhibitors in malignant lymphoma: Advances and perspectives [J].
Lin, Ningjing ;
Song, Yuqin ;
Zhu, Jun .
CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (03) :303-318
[47]   Use of Immune Checkpoint Inhibitors in Mesothelioma [J].
Forde, Patrick M. ;
Scherpereel, Arnaud ;
Tsao, Anne S. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (02)
[48]   PD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature Review [J].
Zhou, Maggie ;
Joshi, Nitin ;
Raj, Kavitha P. ;
Wakelee, Heather ;
Neal, Joel W. .
CLINICAL LUNG CANCER, 2021, 22 (03) :E329-E335
[49]   Inflammatory arthritis due to immune checkpoint inhibitors: challenges in diagnosis and treatment [J].
Cappelli, Laura C. ;
Naidoo, Jarushka ;
Bingham, Clifton O., III ;
Shah, Ami A. .
IMMUNOTHERAPY, 2017, 9 (01) :5-8
[50]   Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges [J].
Regzedmaa, Orgilmaa ;
Zhang, Hongbing ;
Liu, Hongyu ;
Chen, Jun .
ONCOTARGETS AND THERAPY, 2019, 12 :4605-4620
12345